{"nctId":"NCT00561431","briefTitle":"High Dose CVVHDF Compared to Standard Dose CVVHDF","startDateStruct":{"date":"2003-07"},"conditions":["Acute Renal Failure"],"count":200,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Standard dose of dialysis"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Device: High dose of dialysis"]}],"interventions":[{"name":"Standard dose of dialysis","otherNames":[]},{"name":"High dose of dialysis","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female \\> or equal to 19 yrs of age\n* ARF defined by at least one of the following:\n\n  * Volume overload from inadequate urine output despite diuretic agents.\n  * Oliguria (urine output \\< 200 ml/12hrs) despite fluid resuscitation and diuretic administration.\n  * Anuria (urine output \\< 50 ml/12 hrs).\n  * Acute azotemia (BUN \\> or equal to 80 mg/dl).\n  * Acute hyperkalemia not responsive to medication (K+ \\> or equal to 6.5mmol/L)\n  * An increase in serum creatinine of \\> 2.5 mg/dl from normal values or a sustained rise in serum creatinine of \\> or equal to 1 mg/dl over baseline.\n\nExclusion Criteria\n\n* Patients with end stage renal disease\n* Patients who have had more than one previous dialysis session for acute or chronic renal failure during the current hospitalization\n* Patient weight greater than 125 kg\n* Patient weight less than 50 kg\n* Pregnancy\n* Prisoner\n* Non-candidacy for continuous renal replacement therapy (CRRT)\n* Patient/surrogate refusal","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Alive at 30 Days After Enrollment Compared Between High Dose Versus Standard Dose Continuous Venovenous Hemodiafiltration (CVVHDF)","description":"The primary objective is to determine whether Continuous Venovenous Hemodiafiltration (CVVHDF) using an effluent rate of 35 ml/hr/kg (high dose) leads to an increased participant survival time as compared to CVVHDF using the standard effluent rate of 25 ml/hr/kg as measured by days on continuous renal replacement therapy (CRRT) at enrollment up to 30 days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"49","spread":null}]}]}]},{"type":"SECONDARY","title":"Recovery of Renal Function, Defined as Not Requiring Dialysis After Discontinuation of CRRT","description":"The number of participants who recover renal function at 30 days after enrollment in each arm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":63,"n":100},"commonTop":[]}}}